Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07813793) titled 'Role of Triglyceride-Glucose Index and Inflammatory Biomarkers as Prognostic Tools for Progression of Diabetic Nephropathy' on Sept. 5.
Study Type: Observational
Primary Sponsor: Assiut University
Condition:
Diabetes Mellitus
Diabetic Nephropathy
Recruitment Status: Not recruiting
Date of First Enrollment: October 1, 2026
Target Sample Size: 105
To know more, visit https://clinicaltrials.gov/study/NCT07813793
Published by HT Digital Content Services with permission from Health Daily Digest....